Inspirion Wealth Advisors, LLC Biomarin Pharmaceutical Inc Transaction History

Inspirion Wealth Advisors, LLC

$711 Million
Q3 2024

A detailed history of Inspirion Wealth Advisors, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Inspirion Wealth Advisors, LLC holds 13,458 shares of BMRN stock, worth $853,506. This represents 0.13% of its overall portfolio holdings.

Number of Shares

13,458

Previous 13,458 -0.0%

Holding current value

$853,506

Previous $1.11 Million 14.63%

% of portfolio

0.13%

Previous 0.17%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	BUY	$74.43 - $92.22 $37,512 - $46,478	504 Added 3.89%	13,458 $1.11 Million
Q1 2024 Apr 12, 2024	BUY	$83.81 - $99.0 $5,950 - $7,029	71 Added 0.55%	12,954 $1.13 Million
Q4 2023 Jan 10, 2024	BUY	$76.22 - $98.51 $19,817 - $25,612	260 Added 2.06%	12,883 $1.24 Million
Q3 2023 Oct 13, 2023	BUY	$85.07 - $94.48 $61,675 - $68,498	725 Added 6.09%	12,623 $1.12 Million
Q2 2023 Jul 20, 2023	BUY	$86.68 - $100.3 $5,027 - $5,817	58 Added 0.49%	11,898 $1.03 Million
Q4 2022 Jan 18, 2023	BUY	$80.93 - $108.63 $80,930 - $108,630	1,000 Added 9.23%	11,840 $0
Q3 2022 Oct 18, 2022	BUY	$82.16 - $96.94 $36,972 - $43,623	450 Added 4.33%	10,840 $919,000
Q2 2022 Jul 27, 2022	BUY	$71.48 - $86.85 $183,274 - $222,683	2,564 Added 32.76%	10,390 $861,000
Q1 2022 Apr 14, 2022	BUY	$74.28 - $92.69 $170,844 - $213,187	2,300 Added 41.62%	7,826 $603,000
Q4 2021 Jan 21, 2022	SELL	$71.72 - $91.47 $9,251 - $11,799	-129 Reduced 2.28%	5,526 $488,000
Q3 2021 Oct 08, 2021	BUY	$74.77 - $85.47 $41,646 - $47,606	557 Added 10.93%	5,655 $437,000
Q2 2021 Jul 16, 2021	BUY	$75.51 - $84.79 $3,322 - $3,730	44 Added 0.87%	5,098 $425,000
Q1 2021 Apr 15, 2021	BUY	$74.73 - $90.69 $377,685 - $458,347	5,054 New	5,054 $382,000

Others Institutions Holding BMRN

# of Institutions

635

Shares Held

178M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspirion Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inspirion Wealth Advisors, LLC with notifications on news.

Account

Inspirion Wealth Advisors, LLC Biomarin Pharmaceutical Inc Transaction History